10 employees
Oxolife is a biotechnology company in the clinical phase of development.
2013
$2.5M
from 2 investors over 2 rounds
OXOLIFE raised $2.5M on December 13, 2022
Investors: Ministerio de Ciencia, Innovación y Universidades
OXOLIFE raised undisclosed on June 2, 2020
Investors: EIT Health